SCILEX HOLDING CO

Scilex (SCLX) trading highlights: $2.47 price, 52‑week low $2.51, 24‑hour up 1.19%. Learn why the healthcare stock’s non‑opioid pain focus drives value.

Scilex (SCLX) sees a 52% plunge in a volatile health‑care market—why investors must scrutinize its non‑opioid pipeline, regulatory prospects, and cost control before buying back in.

Scilex (SCLX) stock drops 1.56% to $2.56, with a market cap of $18.1 M and a 50‑week range between $2.52–$16.81. Learn key trading data, volume, and future outlook for this non‑opioid pain‑management holding firm.